Skip to main content

altM raises a $10.3m Series A to turn crop residue into specialty chemicals

Bengaluru company altM raised a $10.3m Series A led by Rainmatter by Zerodha and Mela Ventures to turn sugarcane bagasse and rice straw into chemicals.

altM raises a $10.3m Series A to turn crop residue into specialty chemicals

altM, a Bengaluru specialty chemicals company, announced a $10.3 million Series A on 5 November 2026, equivalent to 975 million rupees. Rainmatter by Zerodha and Mela Ventures led the round and both invested for the first time. Existing backers Omnivore, Theia Ventures, Aureolis Ventures and Spectrum Impact joined, alongside strategic angel investors. The round follows a $3.5 million seed in 2023. altM was founded in 2022 by Apoorv Garg, co-founder and chief executive, and Yugal Raj Jain, both of whom previously led manufacturing at Tesla. The bioprocessing scientist Harshad Velankar joined later as chief scientific officer.

The platform fractionates lignocellulosic biomass. Agricultural residue, chiefly sugarcane bagasse and rice straw, is separated into its three main components, cellulose, hemicellulose and lignin, so that one feedstock yields several saleable products rather than a single one. Three products are closest to market: an SPF booster derived from lignin for suncare, a cellulose based rheology modifier, and bio derived ferulic acid for cosmetics and personal care. The company also names textiles, industrial chemicals, construction, packaging and consumer goods as target markets.

On progress, altM says six molecules have reached demonstration scale and three have been selected for pilot plant production, and that its laboratory footprint has grown nearly fivefold in under two years, with a demonstration manufacturing facility commissioned. Inc42 reports a 70 tonne per year pilot plant in Electronic City, Bengaluru, now finishing pre production and certification, close to 30 customers in beauty and personal care of which 16 to 18 are in active testing and validation, six patents filed in India with a seventh in progress, and development time per molecule cut from 12 to 15 months to under six. The stated build out is a 1,000 tonne per year commercial plant by 2028, scaling towards 10,000 tonnes per year over five years, a figure also carried by Dealroom.

Proceeds go to manufacturing capacity, research and development, and customer qualification programmes, with Garg telling Inc42 that the largest share of new spending will go to sales. “We are building a new source of industrial carbon from agricultural residue,” Garg said. Abhinav Negi, who leads climate and deep tech at Rainmatter by Zerodha, pointed to the size of India's domestic agricultural residue base, and Krishnakumar N, managing partner at Mela Ventures, described the company as tackling one of the hardest problems in industrial chemistry. Dealroom places the round against India's BioE3 policy, which favours bio based chemicals over fossil derived inputs.

Why this matters for AgTech founders: notice the order of markets. The first revenue is a suncare ingredient and a cosmetics acid, not a fuel and not a bulk polymer. Personal care tolerates a price per kilogram that biofuel never will, which is what lets a 70 tonne pilot line pay for the engineering needed at 1,000 tonnes. Anyone building on residue should map their molecules by price before capacity, because the cheap end of the curve is where residue projects have historically run out of money. Second, the hard part is upstream of the chemistry. Bagasse arrives already aggregated at sugar mills, while rice straw sits in fields in a two to three week window and has to be baled, stored and kept dry. A plant that can run on either fraction has a supply story; one that needs a single feedstock inherits the harvest calendar. Third, read the qualification numbers as the real milestone. Close to 30 brand customers with roughly half in active testing is a two year sales cycle already part spent, and in personal care a qualified ingredient is slow to displace once it is written into a formulation. That is the asset here, more than the reactor. Residue valorisation in Europe faces the same arithmetic with worse biomass logistics and higher power prices, so the lesson travels: pick the high value molecule, qualify it with brand customers early, and let the plant follow the order book rather than the other way round.

Source: Inc42

altM raises a $10.3m Series A to turn crop residue into specialty chemicals

Rainmatter by Zerodha and Mela Ventures led the round for the Bengaluru company, which splits sugarcane bagasse and rice straw into cellulose, hemicellulose and lignin and sells the fractions into cosmetics first.

By Dirk Vandenhirtz

· Funding · Asia · 4 min

altM, a Bengaluru specialty chemicals company, announced a $10.3 million Series A on 5 November 2026, equivalent to 975 million rupees. Rainmatter by Zerodha and Mela Ventures led the round and both invested for the first time. Existing backers Omnivore, Theia Ventures, Aureolis Ventures and Spectrum Impact joined, alongside strategic angel investors. The round follows a $3.5 million seed in 2023. altM was founded in 2022 by Apoorv Garg, co-founder and chief executive, and Yugal Raj Jain, both of whom previously led manufacturing at Tesla. The bioprocessing scientist Harshad Velankar joined later as chief scientific officer.

The platform fractionates lignocellulosic biomass. Agricultural residue, chiefly sugarcane bagasse and rice straw, is separated into its three main components, cellulose, hemicellulose and lignin, so that one feedstock yields several saleable products rather than a single one. Three products are closest to market: an SPF booster derived from lignin for suncare, a cellulose based rheology modifier, and bio derived ferulic acid for cosmetics and personal care. The company also names textiles, industrial chemicals, construction, packaging and consumer goods as target markets.

On progress, altM says six molecules have reached demonstration scale and three have been selected for pilot plant production, and that its laboratory footprint has grown nearly fivefold in under two years, with a demonstration manufacturing facility commissioned. Inc42 reports a 70 tonne per year pilot plant in Electronic City, Bengaluru, now finishing pre production and certification, close to 30 customers in beauty and personal care of which 16 to 18 are in active testing and validation, six patents filed in India with a seventh in progress, and development time per molecule cut from 12 to 15 months to under six. The stated build out is a 1,000 tonne per year commercial plant by 2028, scaling towards 10,000 tonnes per year over five years, a figure also carried by Dealroom.

Proceeds go to manufacturing capacity, research and development, and customer qualification programmes, with Garg telling Inc42 that the largest share of new spending will go to sales. “We are building a new source of industrial carbon from agricultural residue,” Garg said. Abhinav Negi, who leads climate and deep tech at Rainmatter by Zerodha, pointed to the size of India's domestic agricultural residue base, and Krishnakumar N, managing partner at Mela Ventures, described the company as tackling one of the hardest problems in industrial chemistry. Dealroom places the round against India's BioE3 policy, which favours bio based chemicals over fossil derived inputs.

Why this matters for AgTech founders: notice the order of markets. The first revenue is a suncare ingredient and a cosmetics acid, not a fuel and not a bulk polymer. Personal care tolerates a price per kilogram that biofuel never will, which is what lets a 70 tonne pilot line pay for the engineering needed at 1,000 tonnes. Anyone building on residue should map their molecules by price before capacity, because the cheap end of the curve is where residue projects have historically run out of money. Second, the hard part is upstream of the chemistry. Bagasse arrives already aggregated at sugar mills, while rice straw sits in fields in a two to three week window and has to be baled, stored and kept dry. A plant that can run on either fraction has a supply story; one that needs a single feedstock inherits the harvest calendar. Third, read the qualification numbers as the real milestone. Close to 30 brand customers with roughly half in active testing is a two year sales cycle already part spent, and in personal care a qualified ingredient is slow to displace once it is written into a formulation. That is the asset here, more than the reactor. Residue valorisation in Europe faces the same arithmetic with worse biomass logistics and higher power prices, so the lesson travels: pick the high value molecule, qualify it with brand customers early, and let the plant follow the order book rather than the other way round.

Source: Inc42

Back to AgTech News